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dDsk2 regulates H2Bub1 and RNA polymerase II
pausing at dHP1c complex target genes
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dDsk2 is a conserved extraproteasomal ubiquitin receptor that targets ubiquitylated proteins
for degradation. Here we report that dDsk2 plays a nonproteolytic function in transcription
regulation. dDsk2 interacts with the dHP1c complex, localizes at promoters of developmental
genes and is required for transcription. Through the ubiquitin-binding domain, dDsk2
interacts with H2Bub1, a modiﬁcation that occurs at dHP1c complex-binding sites. H2Bub1 is
not required for binding of the complex; however, dDsk2 depletion strongly reduces H2Bub1.
Co-depletion of the H2Bub1 deubiquitylase dUbp8/Nonstop suppresses this reduction and
rescues expression of target genes. RNA polymerase II is strongly paused at promoters of
dHP1c complex target genes and dDsk2 depletion disrupts pausing. Altogether, these results
suggest that dDsk2 prevents dUbp8/Nonstop-dependent H2Bub1 deubiquitylation at
promoters of dHP1c complex target genes and regulates RNA polymerase II pausing. These
results expand the catalogue of nonproteolytic functions of ubiquitin receptors to the
epigenetic regulation of chromatin modiﬁcations.
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U
biquitin receptors bind ubiquitylated substrates and play a
central role in protein degradation (reviewed in refs 1–3),
an essential process that regulates multiple cellular
functions. They stably associate with the proteasome as
intrinsic subunits (Rpn10 and Rpn13), or only transiently as
extraproteasomal receptors that selectively target ubiquitylated
proteins to the proteasome. Ubiquitin receptors also participate in
autophagy and endolysosomal protein degradation. In addition,
although generally poorly understood, ubiquitin receptors also
play nonproteolytic functions (reviewed in refs 2,4,5). In
particular, it was reported that Rad23 is required for optimal
nucleotide excision repair (NER) in yeast and that this
requirement involves nonproteolytic functions of the 19S
regulatory complex (19S-RC) of the proteasome6–8. The 19S-RC
has also been shown to play nonproteolytic functions in
transcription elongation9. Here we report a novel
nonproteolytic function of the ubiquitin receptor dDsk2 in
transcription regulation. dDsk2 belongs to the UBA/UbL family
of extraproteasomal receptors (reviewed in refs 10,11), where the
ubiquitin-associated (UBA) domain directly binds the ubiquitin
moiety of ubiquitylated substrates12,13 and the ubiquitin-like
(UbL) domain mediates interaction with the proteasome14.
dDsk2 is highly evolutionarily conserved from yeast to
humans10,15,16. We show that, in addition to regulating protein
stability, Drosophila dDsk2 interacts with the complex formed by
the euchromatic dHP1c isoform and the transcription factors
WOC and ROW17–19, localizes at promoters and is required for
transcription via nonproteolytic mechanisms.
Our results indicate that dHP1c complex target genes are
enriched in developmental functions and show features associated
with strong RNA polymerase II (RNA pol II) pausing. Originally
considered a rare event, pausing of the promoter-proximal Pol
IIoser5 form phosphorylated at Ser5 in the C-Terminal Domain
(CTD) is becoming increasingly recognized as a crucial step in
transcription regulation (reviewed in refs 20,21), in particular of
developmentally regulated and stimulus-responsive genes22–25.
Speciﬁc factors such as NELF and DSIF are known to mediate
pausing, and pause release requires their phosphorylation by
P-TEFb. P-TEFb also regulates transition of Pol IIoser5 into the
elongating Pol IIoser2 form, as it phosphorylates Ser2 in the CTD.
Pausing of RNA pol II is accompanied by Pol IIoser5 enrichment
at promoters and results in the production of short RNAs26 and
increased reactivity with KMnO4, which reacts with unpaired
thymines (T) and detects melted DNA at the sites of pausing27.
We also show that, through the UBA domain, dDsk2 interacts
with monoubiquitylated H2B (H2Bub1), an abundant histone
modiﬁcation28 that is induced at promoters during transcription
initiation by an activator-mediated recruitment of the ubiquitin
E2/E3 enzymes Rad6/Bre1 and stimulates additional epigenetic
modiﬁcations required for transcription, such as H3K4me3 and
H3K79me3 (reviewed in refs 29–31). Later, during elongation,
H2Bub1 extends along the entire coding region and facilitates
progression of RNA pol II through chromatin. At promoters,
H2Bub1 levels are dynamically regulated by Ubp8-dependent
deubiquitylation32,33. Our results indicate that dDsk2 protects
H2Bub1 against deubiquitylation by dUbp8/Nonstop and regulates
the release of paused Pol IIoser5 into productive elongation.
In summary, here we report that the ubiquitin receptor dDsk2
plays a nonproteolytic function in transcription, regulating
H2Bub1 deubiquitylation and RNA pol II pausing at promoters
of dHP1c complex target genes.
Results
dDsk2 interacts with dHP1c and is required for transcription.
We and others previously reported that dHP1c interacts with the
transcription factors WOC and ROW17,18. Here to identify
partners of the dHP1c complex, we performed afﬁnity
puriﬁcations using stable S2 cell lines expressing ROW–TAP
and TAP–WOC fused proteins. Co-puriﬁed proteins identiﬁed
with high conﬁdence are listed in Table 1. In addition to dHP1c,
WOC and ROW, these experiments detected the dHP1b
isoform34; the boundary protein BEAF-32 (ref. 35); the
chromosomal proteins Chromator and Z4, which are known to
form a complex36,37; the RNA-binding protein Blanks38; the
ubiquitin receptor protein dDsk2; and coilin, a factor that marks
Cajal bodies and associates to the histone locus39. Co-IP
experiments directly conﬁrmed several of these interactions. In
particular, a strong interaction with dDsk2 was detected, as IPs
performed with adHP1c, aWOC and aROW antibodies bring
down dDsk2 (Fig. 1a) and, vice versa, aDsk2 antibodies co-
immunoprecipitate dHP1c and ROW (Fig. 1b). Furthermore,
glycerol gradient centrifugation shows that a signiﬁcant
proportion of dDsk2 co-sediments with the dHP1c complex
(Fig. 1c). Notice that the poor performance of aWOC antibodies
in western blot (WB) analyses prevented the detection of WOC in
these experiments (see Methods and Supplementary Fig. 11a).
Finally, immunostaining experiments in polytene chromosomes
detected a strong colocalization of dHP1c and dDsk2 (Fig. 1d).
The dHP1c complex was shown to localize at active chromatin
domains, suggesting a role in gene expression regulation17,18.
However, its actual genomic distribution and the extent of
overlapping of its components were not known. To address these
questions, we performed chromatin immunoprecipitation-
sequencing (ChIP-seq) experiments to determine the genomic
binding proﬁles of dHP1c, WOC, ROW and dDsk2. As shown in
Fig. 2a, the four factors predominantly localize at promoters with
B60% of peaks lying within ±1 kb to a transcription start site
Table 1 | Proteins co-purifying with WOC and ROW.
Protein Mascot score Number peptides % Coverage
ROW 2,111 34 55.7%
WOC 1,295 24 37%
Coilin 1,146 18 46.7%
dDsk2 1,133 15 40%
dHP1b 555 10 47.5%
Z4 440 7 12.3%
dHP1c 358 5 35.9%
Blanks 360 6 23.9%
Chromator 264 5 10%
BEAF-32 104 2 10.6%
Proteins co-purifying with ROW–TAP and/or TAP–WOC in at least two independent puriﬁcation experiments are listed. The best mascot scores are indicated.
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(TSS). The distributions of dHP1c, WOC and dDsk2 are centred
at TSS and largely overlap, whereas ROW shows a bimodal
distribution with a major peak slightly displaced downstream
from the TSS and a second peak localizing B0.5 kb upstream
(Fig. 2b). The four factors strongly colocalize (Fig. 2c), with more
than 1,500 common target genes identiﬁed. Common genes
account for a high proportion (B70%) of dHP1c targets but, on
the other hand, they constitute a much lower proportion of WOC
(B30%), ROW (B25%) and dDsk2 (B35%) targets. These
differences appear to largely arise from the different performance
of the antibodies used in ChIP experiments since dHP1c is
detected at WOC/ROW/dDsk2 target genes regardless of whether
they are statistically identiﬁed as dHP1c targets or not. Indeed,
dHP1c abundance at these genes is higher than at non-WOC/
ROW/dDsk2 target genes (Supplementary Fig. 1a) and its
distribution is similar to that observed in target genes
(Supplementary Fig. 1b). Furthermore, ChIP-chip data
generated by the modENCODE project identify a higher
number of dHP1c target genes (Supplementary Fig. 1c), a
majority of which is also detected as WOC/ROW/dDsk2 targets
in our experiments (Supplementary Fig. 1d).
Expression proﬁling analyses indicate that the dHP1c complex is
required for transcription since target genes are actively transcribed
(Fig. 2d) and, on RNA interference (RNAi)-mediated depletion of
ROW,B80% of the target genes changing expression are found to
be downregulated (Fig. 2e). Reverse transcription–quantitative
PCR (RT–qPCR) experiments conﬁrmed these results since several
selected target genes were found to be signiﬁcantly downregulated
on ROW depletion (3.9 10 8oPo0.017, Student’s t-test;
Fig. 2f). WOC and dDsk2 depletion led to a similar effect on
expression but, in contrast, no such downregulation was observed
on dHP1c depletion (Fig. 2f). In this regard, we observed that
dHP1b co-puriﬁes with WOC and ROW (Table 1), co-sediments
(Fig. 1c) and co-immunoprecipitates with dHP1c, ROW and
dDsk2 (Supplementary Fig. 2c), and highly overlaps with dHP1c at
promoters (Supplementary Fig. 2a,b), suggesting that it could
compensate the loss of dHP1c. However, although co-depletion of
dHP1c and dHP1b tends to affect gene expression more than
single dHP1c depletion (Supplementary Fig. 2d), the observed
effects are weaker than when WOC, ROW or dDsk2 are depleted
(Fig. 2f).
Gene ontology analyses show that dHP1c complex target genes
are enriched in developmental functions (Fig. 3a). RNA pol II
pausing is generally high at developmentally regulated genes22–25.
Accordingly, dHP1c complex target genes show features of strong
RNA pol II pausing (Fig. 3b). In comparison with non-target
genes, the distribution of total RNA pol II (RPB1) is strongly
biased towards the TSS. Consequently, the pausing index (PI),
determined as the ratio of total RNA pol II abundance at
TSS±250 bp with respect to the last 500 bp of the gene24, is
signiﬁcantly higher (Po0.0001, Kruskal–Wallis; Fig. 3b).
Concomitantly, Pol IIoser5 is enriched at promoters of B50%
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Figure 1 | The dHP1c complex interacts with dDsk2. (a) dDsk2 co-immunoprecipitates with components of the dHP1c complex. On the top, IPs were
performed with rat polyclonal adHP1c (lane 3), aROW (lane 4) and control aDDP1 (lane 2) antibodies. On the bottom, IPs were performed with rabbit
polyclonal aWOC (lane 3), aROW (lane 4) and control aDDP1 (lane 2). IP materials were analysed by western blot analysis using rabbit polyclonal adDsk2.
Lane 1 corresponds to 2.5% of the input material. At the bottom, the asterisk (*) indicates a band corresponding to IgGs. The position of markers of known
molecular weight (kDa) is indicated. (b) Components of the dHP1c complex co-immunoprecipitate with dDsk2. IPs were performed with rabbit adDsk2
(lane 4), and control aWOC (lane 3) and aDDP1 (lane 2) antibodies, and analysed with western blot analysis using rat polyclonal aROW (top) and adHP1c
(bottom). Lane 1 corresponds to 2.5% of the input material. The position of markers of known molecular weight (kDa) is indicated. (c) Glycerol gradient
(10–30%) sedimentation analysis of a total S2-cell protein extract. Fractions were collected from top to bottom and were analysed with western blot
analysis using rat polyclonal adHP1c, adHP1b and aROW, rabbit polyclonal adDsk2 and mouse polyclonal ap54/Rpn10. Fractions 2–34 are shown. Lane 1
corresponds to 2.5% of the input material. The position of markers of known molecular weight (kDa) is indicated. (d) dHP1c and dDsk2 strongly colocalize.
Polytene chromosomes were immunostained with rat polyclonal adHP1c (green) and rabbit polyclonal adDsk2 (red) antibodies. Enlarged images of the
indicated region are shown at the bottom. DNA was stained with DAPI (blue). Scale bar, 10mm.
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of dHP1c complex target genes (Fig. 3c, left). In addition, target
genes are enriched in NELF (Fig. 3c, centre) and short RNAs
resulting from RNA pol II pausing are detected in as many as
B93% of them (Fig. 3c, right). Furthermore, KMnO4 reactivity is
detected in B94% of target genes (Fig. 3d, left). Most
importantly, target genes are strongly hyper-reactive to KMnO4
since B40% of them show reactivity above the third quartile, in
front of the expected 25% (Po0.0001, Benjamini–Yekutieli-
adjusted Fisher exact test; Fig. 3d, right). This enrichment is
similar to that observed for Pol IIoser5 target genes and
signiﬁcantly higher than for NELF targets (Po0.0001,
Benjamini–Yekutieli-adjusted Fisher exact test; Fig. 3d, right).
dDsk2 plays a nonproteolytic function in the dHP1c complex.
The contribution of the proteasome to transcription regulation
has been extensively documented (reviewed in refs 40–42). In
particular, proteasome-mediated degradation has been shown to
directly affect transcription by coupling transcription factor
turnover to activation. Thus, considering its role in targeting
substrates to the proteasome for degradation, we addressed the
possibility that dDsk2 could mediate dHP1c complex recruitment
to the proteasome and degradation. However, opposite to this
hypothesis, dDsk2 depletion in S2 cells does not increase stability
of the complex; however, it results in a slight decrease in total
dHP1c and ROW content (Fig. 4a). Immunostaining experiments
in wing imaginal discs conﬁrmed these results. In these experi-
ments, we used dsk2RNAi ﬂies to speciﬁcally deplete dDsk2 at the
anterior/posterior (A/P) border using a ptc-GAL4 driver. Under
these conditions, dDsk2 depletion is strong and slightly reduces
dHP1c, WOC and ROW levels, whereas no such reduction is
detected at the A/P border of control ﬂies (Fig. 4b). Moreover, co-
IP experiments failed to detect an interaction with p54/Rpn10,
the proteasome subunit that mediates dDsk2 binding10,11,43,44
(Fig. 4c). Similarly, glycerol gradient centrifugation showed no
detectable p54/Rpn10 co-sedimenting together with the
dHP1c complex (Fig. 1c). In addition, an interaction with the
proteasome is unlikely since the UbL domain is required for both
binding to the proteasome10,11 and assembly into the dHP1c
complex, as aHP1c and aROW antibodies co-immunoprecipitate
overexpressed full-length dDsk2 (Fig. 4d, lanes dDsk2), but not a
truncated form missing the UbL domain (Fig. 4d, lanes DUbL). In
contrast, deleting the UBA domain has no effect (Fig. 4d, lanes
DUBA), indicating that it is dispensable for assembly into the
dHP1c complex.
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Figure 2 | The dHP1c complex localizes at TSS and is required for transcription. (a) ChIP-seq coverage proﬁles of dHP1c, ROW, WOC and dDsk2 across
a representative region. Genomic organization of the region is indicated. Antibodies used were rabbit polyclonal adHP1c, aROW, aWOC and adDsk2.
(b) The distribution around TSS is presented for dHP1c, ROW, WOC and dDsk2. For each gene, the coverage proﬁle was normalized dividing by the average
coverage in that gene. The position of the TSS is indicated. (c) Venn diagram showing the intersection between dHP1c, ROW, WOC and dDsk2 target
genes. (d) Box plot showing the expression in S2 cells of dHP1c, ROW, WOC and dDsk2 target (þ ) and non-target ( ) genes. (e) The percentage of
dHP1c, ROW, WOC and dDsk2 target genes that are found to be differentially down- and upregulated on depletion of ROW in S2 cells is presented.
(f) mRNA levels of six dHP1c complex target genes are determined by RT–qPCR in S2 cells on depletion of dHP1c (purple), ROW (red), WOC (green) and
dDsk2 (blue). mRNA levels were determined in relation to cells treated with dsRNA against LacZ (black). Results were normalized with respect to Tubulin
levels. (Number of experimental replicates, N¼4). Error bars correspond to s.d.
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dDsk2 interacts with and regulates H2Bub1. Ubiquitin recep-
tors usually bind ubiquitylated substrates. Thus, we addressed the
possibility that, through the UBA domain, dDsk2 might recognize
an ubiquitylated chromatin component. In this regard, a promi-
nent feature of dHP1c complex-binding sites is the presence of
H2Bub1 (Fig. 5a), suggesting that dDsk2 might interact with
H2Bub1. Peptide pull-down assays support this possibility since
the UBA domain of dDsk2 strongly binds a biotinylated H2B
peptide encompassing the ubiquitylation site, K118 in Drosophila,
only when it is ubiquitylated (H2BubK118; Fig. 5b, row UBA).
Notice that full-length dDsk2 binds H2BubK118 very inefﬁciently
(Fig. 5b, row dDsk2), while deleting the UbL domain restores
binding (Fig. 5b, row DUbL). Most probably, this observation
reﬂects the UbL–UBA self-interaction that is known to occur
in vitro and blocks recognition of ubiquitylated substrates45.
Furthermore, overexpression experiments in S2 cells showed that
the UBA domain stabilizes the binding of dDsk2 to chromatin
since full-length dDsk2 is detected in both the cytosolic and
chromatin-bound fractions, and deleting the UBA domain
reduces binding to chromatin (Fig. 5d). Concomitantly,
overexpression of the DUBA–dDsk2 construct signiﬁcantly
downregulates expression of targets genes (Po0.01, Student’s t-
test; Fig. 5e), which is similar to the effect of dDsk2 depletion,
indicating that the truncated DUBA–dDsk2 form has a
dominant-negative character. Notice that the DUBA–dDsk2
form assembles efﬁciently into the dHP1c complex (Fig. 4d).
However, reducing H2Bub1 levels by Rad6/Bre1 depletion has
only a weak effect on binding of dDsk2, WOC and ROW (Fig. 5f).
Altogether, these results suggest that, although the interaction of
dDsk2 with H2Bub1 is important for transcription and stabilizes
binding of the complex, it is not essential for its recruitment to
promoters. In this regard, the zinc-ﬁnger proteins WOC and
ROW mediate binding of both dHP1c18 and dDsk2
(Supplementary Fig. 3a,b), suggesting that they play a crucial
role in recruitment. However, although largely independent of the
interaction with H2Bub1, binding of the complex also requires
dDsk2 (Supplementary Fig. 3c,d).
Ubiquitin receptors have also been shown to protect
ubiquitylated conjugates against deubiquitylation10,11,
suggesting that dDsk2–H2Bub1 interaction could prevent
H2Bub1 deubiquitylation. Consistent with this hypothesis,
dDsk2 depletion strongly reduces H2Bub1 at promoters of
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target genes (Po0.01, Student’s t-test; Fig. 6a). Similarly,
overexpression of the DUBA–dDsk2 form also reduces H2Bub1
levels (Po0.05. Student’s t-test; Fig. 6b). Furthermore, depletion
of the H2Bub1 deubiquitylase dUbp8/Nonstop suppresses this
effect since, on dDsk2 and dUbp8/Nonstop co-depletion, H2Bub1
levels are higher than when only dDsk2 is depleted (Po0.001,
Student’s t-test) and similar to those observed in control cells
(Fig. 6c, top). These changes in H2Bub1 levels are not due to
differential nucleosome occupancy, as H3 abundance is similar in
control and knockdown conditions (Fig. 6c, bottom). In addition,
expression of target genes, which is strongly decreased on dDsk2
depletion, is signiﬁcantly rescued when dUbp8/Nonstop is co-
depleted (Po0.001, Student’s t-test; Fig. 6d), whereas binding of
both WOC and ROW is not (Fig. 6e).
dHP1c complex target genes show features associated with
strong RNA pol II pausing (Fig. 3). Thus, we considered the
possibility that the contribution of dDsk2 to transcription reﬂects
a role in RNA pol II pausing. To address this question, we
determined the distribution of total RNA pol II (RPB3) and the
promoter-proximal Pol IIoser5 form across target genes (Fig. 7a).
In both cases, strong accumulation is detected at TSS in control
cells as well as on dUbp8/Nonstop depletion. In contrast, dDsk2
depletion reduces RPB3 and Pol IIoser5 occupancy all across the
gene. Importantly, this reduction preferentially occurs at the
promoter, as relative abundance at TSS with respect to the total
abundance across the gene is signiﬁcantly reduced in dDsk2-
depleted cells (Po0.05, Student’s t-test; Fig. 7b), which suggests a
defect in pausing. In good agreement, dDsk2 depletion sig-
niﬁcantly reduces NELF-E occupancy at TSS (Po0.02, Student’s
t-test; Fig. 7c). Furthermore, NELF-E depletion induces a similar
decrease in RNA pol II occupancy across the gene, which is
signiﬁcantly stronger at TSS (Po0.05, Student’s t-test;
Supplementary Fig. 4). Besides, the extent of histone acetylation
at the promoter remains high (Fig. 7d), indicating that the active
chromatin conﬁguration of the promoter is retained on dDsk2
depletion. In contrast, dDsk2 depletion induces a strong
reduction of H3K4me3 at promoters (Fig. 7d), as expected from
the reported H2Bub1–H3K4me3 crosstalk29–31. Notably, co-
depletion of Ubp8/Nonstop, which rescues H2Bub1 and
expression (Fig. 6c,d), also rescues RPB3 and Pol IIoser5 levels
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at TSS (Fig. 7a,b). Finally, in a control gene whose expression is
not affected by dDsk2 depletion (Supplementary Fig. 5a, left), the
levels of H2Bub1 (Supplementary Fig. 5b, left), and RPB3 and Pol
IIoser5 at TSS (Supplementary Fig. 5c) are unchanged on dDsk2
depletion. Similarly, overexpression of the DUBA–dDsk2
construct does not affect expression (Supplementary Fig. 5a,
right) or H2Bub1 levels (Supplementary Fig. 5b, right).
Similar to dDsk2 depletion, depletion of dBre1 reduces
H2Bub1 levels at TSS (Figs 5f and 8a) and downregulates
expression of target genes (Po0.01, Student’s t-test; Fig. 8b).
Thus, we also analysed its effect on RNA pol II pausing. As shown
in Fig. 8c,d, dBre1 depletion does not signiﬁcantly reduce RPB3
and Pol IIoser5 levels at TSS, suggesting that pausing is not
impaired. Co-depletion of dUbp8/Nonstop and dBre1 restores
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H2Bub1 levels (Fig. 8a) and maintains normal RPB3 and Pol
IIoser5 levels at TSS (Fig. 8c,d). However, it has little effect in the
expression of target genes (Fig. 8b), which is in contrast to what is
observed in dDsk2-depleted cells, where dUbp8/Nonstop co-
depletion strongly rescues expression (Fig. 6d).
Discussion
Here we report that the extraproteasomal ubiquitin receptor dDsk2
interacts with the dHP1c complex, localizes at promoters and is
required for transcription (Figs 1 and 2). Binding sites of the
dHP1c complex are marked by H2Bub1 and our results suggest
that, through the UBA domain, dDsk2 binds H2Bub1 (Fig. 5).
However, reducing H2Bub1 levels affects binding of the complex
only weakly (Fig. 5f), indicating that the interaction with H2Bub1
has only a minor contribution to recruitment. Actually, dDsk2
contains a single ubiquitin-binding site of low afﬁnity (KdB400
mM), which is in contrast to most ubiquitin receptors that contain
several ubiquitin-binding sites that act synergistically to provide
high-afﬁnity binding2,3,46. Similarly, the interaction of dDsk2 with
H2Bub1 is of low speciﬁcity since selective recognition of
ubiquitylated substrates is largely based on the recognition of the
linkage type, length and anchoring site of a polyubiquitin
chain2,3,46, and, consequently, requires the presence of several
ubiquitin-binding sites. In fact, the UBA domain of dDsk2
recognizes a monoubiquitylation in PTEN with a similar afﬁnity
as in H2B (Fig. 5c). On the other hand, binding of the dHP1c
complex likely involves the recognition of speciﬁc DNA sequences
since it depends on the zinc-ﬁnger proteins WOC and ROW18
(Supplementary Fig. 3a,b). Noteworthy, dHP1c complex-binding
Fo
ld
 e
nr
ic
hm
en
t
Fo
ld
 e
nr
ic
hm
en
t
Fo
ld
 e
nr
ic
hm
en
t
Fo
ld
 e
nr
ic
hm
en
t
R
el
at
ive
 e
xp
re
ss
io
n
1.0
0.5
0.0
1.0
0.5
0.0
–116.5
–116.5
–40 –79
–79–40
–116.5 –79–40
–116.5 –79–40
1.0
0.5
0.0
0.5
1.5
1
0
0.5
1
0
0.5
1
0
0.5
1
0
0.5
1
0
0.5
1
0
0.5
1
0
0.5
1.5
1
0
–116.5
–116.5
Distance to TSS (bp)
Distance to TSS (bp)
Distance to TSS (bp)
Distance to TSS (bp)
–40
H3 H3H3
H2Bub1 H2Bub1 H2Bub1
CG3919
CG3919
CG3919
Pgm
Pgm
Pgm
CG14527
CG14527
CG3919PgmCG14527
CG14527
CG3919Pgm
ROW ROWROW
WOC WOC WOC
1
0.8
0.6
0.4
0.2
0
1
0.8
0.6
0.4
0.2
0
1
0.8
0.6
0.4
0.2
0
CG14527
H2Bub1H2Bub1
ds
la
cZ
ds
Ds
k2
ds
RO
W
Co
nt
ro
l
D
sk
2 Δ
UB
A
Co
nt
ro
l
Co
nt
ro
l
D
sk
2 D
sk
2Δ
UB
A
ΔU
BA
ds
W
O
C
ds
la
cZ
ds
la
cZ
ds
Ds
k2
ds
Ds
k2
ds
Ds
k2
ds
Ub
p8
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
la
cZ
ds
Ds
k2
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
la
cZ
ds
Ds
k2
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
la
cZ
ds
la
cZ
ds
Ds
k2
ds
Ds
k2
ds
Ub
p8
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
Ds
k2
+d
sU
bp
8
ds
la
cZ
ds
Ds
k2
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
la
cZ
ds
Ds
k2
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
la
cZ
ds
Ds
k2
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
la
cZ
ds
Ds
k2
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
la
cZ
ds
Ds
k2
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
la
cZ
ds
Ds
k2
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
la
cZ
ds
Ds
k2
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
la
cZ
ds
Ds
k2
ds
Ub
p8
ds
Ds
k2
+d
sU
bp
8
ds
Ub
p8
ds
la
cZ
ds
Ds
k2
ds
Ds
k2
ds
Ub
p8
ds
Ub
p8
ds
la
cZ
ds
Ds
k2
ds
RO
W
ds
W
O
C
ds
la
cZ
ds
Ds
k2
ds
RO
W
ds
W
O
C
H2Bub1
H2Bub1H2Bub1H2Bub1
–40
–79
–79
0.5
1.5
1
2
00
1
2
3
0
1
2
3
0.5
1
0
0.5
1
0
0.5
1
0
0.5
1.5
1
0
Figure 6 | dDsk2 regulates H2Bub1 deubiquitylation at promoters of dHP1c complex target genes. (a) H2Bub1 levels at the indicated positions with
respect to TSS of selected target genes are determined by ChIP–qPCR in control S2 cells treated with dsRNA against LacZ (black) and on depletion of
dDsk2, ROW and WOC (red). Results are presented as fold enrichment with respect to the control (dsLacZ). Antibodies used were mouse monoclonal
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Results are presented as fold enrichment with respect to control cells expressing no construct (black; N¼ 3). (c) As in a, but for H2Bub1 (top) and H3
(bottom) levels on depletion of dDsk2 (red), dUbp8/Nonstop (yellow) and both (blue; N¼ 3). (d) mRNA levels of the indicated target genes are
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sites are signiﬁcantly enriched in a speciﬁc DNA sequence motif
(Supplementary Fig. 6). However, although the interaction with
H2Bub1 is weak, binding of the complex unexpectedly depends on
dDsk2 (Supplementary Fig. 3c,d). Besides, dHP1c is dispensable
for WOC and ROW binding18, as well as for dDsk2 binding
(Supplementary Fig. 3a, bottom panel). These effects do not appear
to be the consequence of changes in gene expression levels since
dDsk2 mRNA levels do not signiﬁcantly change on WOC, ROW
or dHP1c depletion (Supplementary Fig. 7). Furthermore, dDsk2
depletion upregulates ROW and weakly downregulates dHP1c
mRNA levels (Supplementary Fig. 7). Finally, it was reported that
dHP1c interacts with RNA pol II17–19, suggesting that binding of
the dHP1c complex might depend on RNA pol II. However,
arguing against this possibility, we observed that binding of the
complex at promoters is resistant to treatment with Actinomycin
D (Supplementary Fig. 8). Altogether, these results suggest that
WOC, ROW and dDsk2 constitute the actual binding module of
the complex, being fully interdependent for binding to chromatin
and required for binding of dHP1c. In this regard, the slight
reduction of ROW and dHP1c protein levels observed on dDsk2
depletion (Fig. 4a,b) is most likely due to their inability to bind
chromatin, as described previously for dHP1c in ROW and WOC
knockdowns18, as well as for other chromatin-associated proteins
when their binding to chromatin is impaired47,48.
Our results suggest that the main function of dDsk2 in the
dHP1c complex is to prevent H2Bub1 deubiquitylation by
1.5
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Figure 7 | dDsk2 regulates RNA pol II pausing at promoters of dHP1c complex target genes. (a) The levels of RPB3 (top) and the promoter-proximal Pol
IIoser5 form (bottom) across selected target genes are determined by ChIP–qPCR at the indicated positions with respect to TSS in control S2 cells treated
with dsRNA against LacZ (black) and on depletion of dDsk2 (red), dUbp8/Nonstop (yellow) and both (blue). Results are presented as fold enrichment with
respect to the control (dsLacZ) at the most proximal position to the TSS. The position of the TSS is indicated. Antibodies used were rabbit polyclonal aRPB3
and aIIoser5 (N¼ 3). (b) The relative abundance of RPB3 (black) and Pol IIoser5 (red) at TSS with respect to their total abundance across the gene is
determined for the indicated target genes in control S2 cells treated with dsRNA against LacZ and on depletion of dDsk2, dUbp8/Nonstop and both
(N¼ 3). (c) NELF-E levels at the indicated positions with respect to TSS of selected target genes are determined by ChIP–qPCR in control S2 cells treated
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levels at the indicated positions with respect to TSS of selected target genes are determined by ChIP–qPCR in control S2 cells treated with dsRNA against
LacZ (black) and on depletion of dDsk2 (red). Results are presented as fold enrichment with respect to the control (dsLacZ). Antibodies used were rabbit
polyclonal aH3K4me3, aPanAc and aAcH4 (N¼ 3). Error bars correspond to s.d.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8049 ARTICLE
NATURE COMMUNICATIONS | 6:7049 | DOI: 10.1038/ncomms8049 |www.nature.com/naturecommunications 9
& 2015 Macmillan Publishers Limited. All rights reserved.
dUbp8/Nonstop, as H2Bub1 levels are strongly reduced on dDsk2
depletion and recovered after dUbp8/Nonstop co-depletion
(Fig. 6c). Protection against deubiquitylation has also been
reported for Rad23 (refs 49,50) and appears to be a common
feature of many ubiquitin receptors10,11. Simultaneous dDsk2 and
dUbp8/Nonstop depletion also restores expression of target genes
(Fig. 6d), whereas it has no effect on recruitment of the complex
at promoters (Fig. 6e). Furthermore, overexpression of the
DUBA–dDsk2 construct, which misses the UBA domain that
mediates interaction with H2Bub1 in vitro (Fig. 5b), reduces
H2Bub1 levels at promoters (Fig. 6b) and downregulates
expression of target genes (Fig. 5e). Altogether, these results
strongly suggest that the contribution of dDsk2 to transcription
regulation is mainly based on this protective function.
dHP1c complex target genes show features associated with
strong RNA pol II pausing (Fig. 3). Our results support a
contribution of dDsk2 to pausing since its depletion reduces RNA
pol II occupancy preferentially at TSS (Fig. 7b) and strongly
decreases NELF-E levels (Fig. 7c). dDsk2 depletion downregulates
expression (Fig. 2f) and, in good agreement, total RNA pol II
occupancy across target genes is reduced (Fig. 7a). Interestingly,
the majority of NELF target genes are also downregulated on
NELF depletion in S2 cells51, and NELF potentiates gene
expression in the Drosophila embryo52. Actually, B80% of
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Figure 8 | dBre1 depletion does not affect RNA pol II occupancy at TSS. (a) H2Bub1 levels at the indicated positions with respect to TSS of selected
target genes are determined by ChIP–qPCR in control S2 cells treated with dsRNA against LacZ (black) and on depletion of dBre1 (green) and co-depletion
of dBre1 and dUbp8/Nonstop (blue). Results are presented as fold enrichment with respect to the control (dsLacZ). Antibodies used were mouse
monoclonal aH2Bub1 (N¼ 3). (b) mRNA levels of the indicated target genes are determined by RT–qPCR in S2 cells on depletion of dBre1 (green) and co-
depletion of dBre1 and dUbp8/Nonstop (blue). mRNA levels were determined in relation to control cells treated with dsRNA against LacZ (black). Results
were normalized with respect to Actin5C levels (N¼ 3). (c) The levels of RPB3 (top) and the promoter-proximal Pol IIoser5 form (bottom) across selected
target genes are determined by ChIP–qPCR at the indicated positions with respect to TSS in control S2 cells treated with dsRNA against LacZ (black) and
on depletion of dBre1 (green) and co-depletion of dBre1 and dUbp8/Nonstop (blue). Results are presented as fold enrichment with respect to the control
(dsLacZ) at the most proximal position to the TSS. The position of the TSS is indicated. Antibodies used were rabbit polyclonal aRPB3 and aIIoser5 (N¼ 3).
(d) The relative abundance of RPB3 (black) and Pol IIoser5 (red) at TSS with respect to their total abundance across the gene is determined for the indicated
target genes in control S2 cells treated with dsRNA against LacZ and on depletion of dBre1 and co-depletion of dBre1 and dUbp8/Nonstop (N¼ 3). Error
bars correspond to s.d.
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dHP1c complex target genes that change expression in NELF
knockdown conditions are downregulated. Furthermore, NELF-E
depletion shows a similar reduction of total RNA pol II
occupancy across target genes (Supplementary Fig. 4).
Altogether, these observations suggest that disrupting RNA pol
II pausing does not generally increase productive transcription,
but results in reduced total RNA pol II occupancy and decreased
expression. It is possible that premature pause release interferes
with RNA pol II activation into elongation, resulting in abortive
transcription that, in turn, could affect RNA pol II recruitment
and/or re-initiation. Notice, however, that dDsk2 depletion
does not affect the extent of histone acetylation detected at
target promoters (Fig. 7d), suggesting that they retain the
transcriptional active chromatin state.
Notably, co-depletion of dUbp8/Nonstop, which rescues
H2Bub1 (Fig. 6c), also rescues the pausing defect caused by dDsk2
depletion (Fig. 7a,b) and expression levels are restored (Fig. 6d),
suggesting that dynamic regulation of H2Bub1 levels at promoters
of dHP1c target genes plays a role in RNA pol II pausing. In this
regard, work performed in yeast suggested that transcriptional
activation involves sequential cycles of H2B ubiquitylation and
deubiquitylation32 and that Ubp8 promotes Ctk1-dependent
phosphorylation of Ser2 in the CTD33, a modiﬁcation that is
required for activation into the elongating Pol IIoser2 form.
Nevertheless, H2Bub1 deubiquitylation at TSS does not appear to
be sufﬁcient by itself to induce pause release since dBre1 depletion,
which also reduces H2Bub1 at TSS (Figs 5f and 8a), has no
signiﬁcant effect in pausing (Fig. 8c,d). In this regard, it must be
noted that dBre1 travels with the elongating RNA pol II along
coding regions to induce H2Bub1, which stimulates Facilitates-
Chromatin-Transcription (FACT) activity and, thus, facilitates
elongation29–31,53. On the other hand, dUbp8/Nonstop activity is
mainly restricted to promoters since its depletion in dBre1-
deﬁcient cells has little effect in H2Bub1 levels at coding regions
(Supplementary Fig. 9). On the contrary, dUbp8/Nonstop
depletion in dDsk2-deﬁcient cells strongly rescues H2Bub1 levels
at coding regions (Supplementary Fig. 9). Interestingly, whereas
dUbp8/Nonstop depletion restores expression of target genes in
dDsk2-depleted cells (Fig. 6d), it has only a slight effect in dBre1-
deﬁcient cells (Fig. 8b). Altogether, these results suggest that dBre1
depletion impairs elongation and, thus, might prevent the release
of paused RNA pol II by disturbing its actual engagement into
elongation. Further work is required to better understand the
mechanisms that regulate RNA pol II pausing, the actual
contribution of dDsk2 and whether it involves H2Bub1 and/or
additional factors also targeted by ubiquitylation.
The dHP1c complex appears to have a particularly important
contribution to nervous system development and function since
target genes are enriched in related functions (Fig. 3a) and
knockdown conditions preferentially affect gene expression in the
nervous system18. Actually, WOC and ROW are highly expressed
in the nervous system during embryo and larval development,
and mutant larvae show brain defects54,55. Furthermore, in
humans, the WOC homologue DXS6673E/ZNF261 has been
implicated in X-linked mental retardation56. Interestingly,
mutations in the human Dsk2 homologues (Ubqln-1/2) have
been associated with Alzheimer’s disease as well as other
neurodegenerative diseases57. Noteworthy, Ubqln-1/2 are
detected in both the nucleus and the cytoplasm, and the
development and progression of neuroﬁbrillary tangles in
Alzheimer’s disease brains associate with an altered nuclear
Ubqln-1 content58. Whether the role of dDsk2 in transcription
regulation is conserved in humans and contributes to disease
remains to be determined.
In summary, our results indicate that the ubiquitin receptor
dDsk2 plays a nonproteolytic function in the regulation of
H2Bub1 and RNA pol II pausing at promoters of dHP1c complex
target genes. Ubiquitin receptors have been previously reported to
play nonproteolytic functions in DNA repair and transcription
elongation6–9. Furthermore, in response to DNA damage, human
Rad23B was found to interact with ubiquitylated p53, localize at
chromatin and accumulate at the p21 promoter59. In addition, in
mouse embryonic stem cells, several components of the NER
complex, including Rad23B, have been shown to act as an Oct4/
Sox2 co-activator complex that associates with chromatin and is
required for stem cell maintenance60. Recruitment of NER factors
to active promoters has also been reported in HeLa cells in the
absence of DNA damage61. However, in these cases, the precise
function of the ubiquitin receptor has not been elucidated. In this
regard, our results expand the catalogue of nonproteolytic
functions of ubiquitin receptors to the epigenetic regulation of
chromatin modiﬁcations and transcription initiation. It must also
be noted that ubiquitylation participates in the regulation of
multiple genomic functions and that the number of proteins
containing ubiquitin-binding domains is large,B100 in humans.
Therefore, a role of ubiquitin-binding proteins as epigenetic
regulators of chromatin emerges as a distinct possibility.
Methods
Drosophila stocks and genetic procedures. hp1cRNAi, rowRNAi and wocRNAi lines
are described in ref. 18. dsk2RNAi was obtained from the Vienna Drosophila
Resource Center (VDRC) and correspond to line 47448. act5C-GAL4, ptc-GAL4
and lio-GAL4 were obtained from the Bloomington Stock Center. For RNAi
depletion, crosses were set up at 25 C and moved to 29 C 3 days before dissection.
Efﬁciency of depletion by hp1cRNAi, rowRNAi and wocRNAi is reported in ref. 18.
Efﬁciency of depletion by dsk2RNAi was determined by immunostaining with
adDsk2 antibodies in polytene chromosomes (Supplementary Fig. 10) and wing
imaginal discs (Fig. 4b).
Antibodies. Polyclonal rabbit aHP1c (ChIP/IP: 5 ml) and aHP1b (ChIP/IP: 5ml)
were custom made by ABGENT against peptides aa143–157 and aa219–233,
respectively. Polyclonal rat aWOC (IF: 1/500) and rabbit aROW (WB: 1/10,000,
ChIP/IP: 1 ml) antibodies were raised against recombinant proteins aa230–626 and
aa588–956, respectively. Other antibodies used are described in the indicated
references: rat aHP1c (WB: 1/10,000, IF: 1/500, ChIP/IP: 1 ml), aHP1b (WB: 1/
10,000, ChIP/IP: 1 ml) and aROW (WB: 1/10,000, IF: 1/400, ChIP/IP: 1 ml)18, rabbit
aWOC (WB: 1/10,000, ChIP/IP: 1 ml)62, rabbit and rat aDDP1 (ChIP/IP: 1ml)63,
rabbit adDsk2 (WB: 1/12,000, IF: 1/1,000, ChIP/IP: 1 ml)16, mouse ap54 (WB:
1/50)64, rabbit aNELF-E (WB: 1/500, ChIP/IP: 3 ml)65 and rabbit aRPB3 (WB:
1/1,500, ChIP: 15 ml)26. Commercially available antibodies used were as follows:
rabbit aH3K4me3 (Abcam, ab8580, ChIP: 1 ml), rabbit aIIoser5 (Abcam, ab5131,
ChIP: 3 ml), rabbit aBre1 (NOVUS, 40280002, WB: 1/1,000, ChIP: 2 ml) and aRad6
(SANTA CRUZ, sc-30078, WB: 1/500, ChIP: 2 ml), mouse aGST (glutathione
S-transferase; Novagen, 71097-3, WB: 1/10,000), mouse aGFP (Roche, 1814460, IF:
1/50), mouse aH2Bub1 (Millipore, 05–1312, WB: 1/4,000, ChIP/IP: 1 ml), mouse
aTubulin (Millipore, MAB3408, WB: 1/2,000), rabbit aActin (Sigma, A2066, WB:
1/10,000), mouse aV5 (Invitrogen, 460705, WB: 1/5,000), mouse aUbiquitin
(SANTA CRUZ, sc-8017, WB: 1/500), rabbit aPanAc (Abcam, Ab193–100, ChIP:
1 ml) and rabbit aH4Ac (Millipore, no. 06–866, ChIP: 1 ml). Dilutions used in
immunostaining (IF), ChIP, IP and WB experiments are indicated.
Constructs. Full-length Row-coding sequence was cloned into pMK33-C-TAP.
Full-length Woc-coding sequence was cloned into pMK33-NTAP. dDsk2 full-length
and deletion constructs were generated using the pAc5.1/V5-HisA (Invitrogen) and
the pGEX-2TK (Amersham) vectors. dDsk2–DUbL is lacking aa1–80, dDsk2–
DUBA is lacking aa496–547 and dDsk2–UBA corresponds to aa469–547.
Complex puriﬁcation and characterization. Stable S2 cell lines were generated
using the plasmids pMK33-ROW-TAP and pMK33-TAP-WOC. TAP-tagged
expression was induced by overnight treatment with 0.07mM CuSO4. Crude
nuclear extracts were prepared according to conventional methods and precleared
by incubation with BSA Dynabeads (Invitrogen) for 1 h at 4 C. Then, the pre-
cleared extracts were incubated with IgG Dynabeads for 4 h at 4 C in Buffer B
(20mM HEPES pH 7.9, 20% Glycerol, 0.3M NaCl, 3mM MgCl2, 1mM EGTA and
1mM dithiothreitol (DTT), Protease Inhibitor Cocktail). After incubation, the
beads were extensively washed with Wash Buffer (20mM HEPES pH 7.9, 20%
Glycerol, 0.3M NaCl, 0.1% NP-40, 0.5mM EGTA and 0.5mM DTT, Protease
Inhibitor Cocktail). Elution was performed with 50mM Glycin-HCl pH3. Aliquots
were checked with SDS–PAGE and silver staining. The remaining eluate was run
into a stacking gel, from where a single band was cut and interacting proteins were
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identify using LC/MS at the Proteomics Unit of the ‘Institut de Recerca de la Vall
d’Hebron’ Barcelona.
Co-IP experiments. Co-IPs were performed using extracts from S2 cells or
transiently transfected S2 cells with dDsk2-V5 expression constructs. Cells were
lysed in IP buffer (50mM Tris-HCl pH 8, 250mM NaCl, 5mM EDTA, 0.5% NP-
40 and Protease Inhibitor cocktail). Extracts were incubated with antibodies in IP
buffer overnight at 4 C. Then, Protein A sepharose (GE Healthcare) or Protein G
agarose (Santa Cruz Biotechnology) was added and further incubated at 4 C for
2 h. After several washes with IP buffer, the beads were eluted in SDS-loading
buffer and the results were analysed using WB analysis.
Glycerol gradient sedimentation. Total soluble extracts were prepared from S2
cells in 225mM NaCl, 50mM Tris-HCl pH 8, 5mM EDTA, 0.5% NP-40, 0.1mM
phenylmethylsulphonyl ﬂuoride (PMSF) and Protein Inhibitor Cocktail, and 250 ml
of extract were loaded on a 12-ml 10–30% glycerol gradient in 10mM Tris-HCl pH
8, 100mM KCl, 12.5 mM EDTA. Centrifugation was carried out in an SW40.1ti
rotor at 35,000 r.p.m. (RCFmax¼ 217,874 g) for 20 h at 4 C. Fractions of 350 ml
were collected from the top of the gradient and analysed using WB analysis.
Pull-down assays. For peptide pulldowns, 2 mg of the corresponding GST con-
struct and 0.25 nmol of the corresponding biotinylated peptide were incubated
overnight at 4 C with streptavidin sepharose in peptide-binding buffer (50mM
Tris-HCl pH 8, 100mM NaCl, 0.1% NP-40, 1mM DTT and Protease Inhibitor
Cocktail) in a total volume of 500 ml. Then, the beads were washed three times with
1ml peptide-binding buffer and eluted in SDS-loading buffer. The results were
analysed with WB analysis using mouse aGST. Custom-made N-terminally bio-
tinylated Drosophila H2B peptides corresponding to aa104–124 either ubiquity-
lated (H2BubK118) or unmodiﬁed at K118 (H2BK118) were purchased from
UbiQ.
To determine the speciﬁcity of the binding of the UBA domain of dDsk2 to
H2Bub1, we performed GST pull-down assays. In this case, glutathione sepharose
4B beads were incubated with the GST–UBA construct in the presence of either the
H2BubK118 peptide or a PTENubK13 peptide (aa5–21) ubiquitylated at K13
(LifeSensors, UP100). Binding was analysed with WB analysis using mouse
aUbiquitin (Santa Cruz).
Overexpression experiments. For overexpression experiments, 3 million cells
were seeded in 5ml dishes and cultured overnight. Then, each dish was transfected
using the CaCl2 precipitation method with 24 mg of plasmid DNA: empty pAc5.1
(control), pAc5.1-Dsk2 full-length (Dsk2) or pAc5.1-Dsk2 (1–495) (DUBA–Dsk2).
Cells were collected 48 h after transfection.
Cellular fractionation. S2 cells were collected 2 days after transient transfection of
the indicated constructs and spun down for 5min at 1,000g. The cell pellet was
washed two times with PBS. The pellet was then resuspended in Buffer A (10mM
HEPES pH 7.9, 10mM KCl, 1.5mM MgCl2, 0.34M Sucrose, 10% Glycerol, 1mM
DTT and Protease Inhibitor cocktail). Triton X-100 was added to ﬁnal 0.1% and
the sample was gently mixed and incubated on ice for 8min. Then, centrifugation
was carried out for 5min at 1,300g resulting in pellet P1 (nuclei) and supernatant
S1. To obtain the cytosolic fraction S1 was clariﬁed by centrifugation at 16,000g for
10min. The pellet P1 was washed in Buffer A and then lysed for 30min in Buffer B
(10mM HEPES pH 7.9, 3mM EDTA, 0.2mM EGTA, 1mM DTT and Protease
Inhibitor Cocktail). Then, centrifugation was carried out at 1,700g for 5min
resulting in supernatant S3 (soluble nuclear fraction) and in pellet P3. After
washing P3 with Buffer B, pellet P4 (chromatin) was obtained. The total extracts
were prepared in parallel by lysing pellets of S2 directly in SDS-loading buffer.
Equivalent amounts of total extracts and cellular fractions were analysed using WB
analysis.
Immunostaining experiments. Immunostaining experiments were performed in
polytene chromosomes and imaginal discs of third instar larvae according to ref.
18. For visualization, slides were mounted in Mowiol (Calbiochem-Novabiochem)
containing 0.2 ngml 1 DAPI (Sigma) and visualized in a Nikon Eclipse E-800
inverted microscope.
RNAi knockdown experiments in S2 cells. dsRNA was prepared using the
MEGAscript T7 kit (Ambion). For knockdown in S2 cells, cells were diluted to
106ml 1 and incubated for 2 days with 4 mg dsRNA per 106 cells. Then, they were
diluted again to 106ml 1 and incubated for 3 more days after addition of another
4 mg dsRNA per 106 cells. Then, cells were collected and used for consecutive
experiments. An aliquot was taken to check the knockdown efﬁciency using WB
analysis (Supplementary Fig. 11). Notice that rabbit polyclonal aWOC does not
give rise to any speciﬁc signal. Therefore, in this case, the extent of depletion was
determined from the destabilization of dHP1c observed when its binding to
chromatin is impaired in the absence of WOC or ROW18. Primers used for dsRNA
production are described in Supplementary Table 1.
Expression proﬁling and RT–qPCR experiments. For expression proﬁling ana-
lyses, total RNAs were prepared from control S2 cells and on RNAi-mediated
depletion of ROW, converted to cDNA, hybridized to Drosophila Genome 2.0
GeneChip (Affymetrix) and analysed essentially as described in ref. 66. Microarray
data were deposited in the NCBI Gene Expression Omnibus repository
(GSE49103). To assess differential expression, we used the limma-moderated t-test
statistics to compute posterior probabilities of differential expression, following the
empirical Bayes semiparametric procedure described in ref. 67 and setting the false
discovery rate at 0.05. NELF knockdown microarray data were downloaded from
NCBI GEO (GSE6141)51.
For expression analysis of selected target genes by RT–qPCR, RNA was
prepared from S2 cells using a combination of Trizol (Ambion) and RNeasy mini
kit (Qiagen). RNA was retro-transcribed using the Transcriptor First Strand cDNA
Synthesis Kit (Roche) with oligo (dT)18 primers. Real-time PCR was performed
using the standard curve method. Normalization was carried out against the
control gene aTubulin and then fold change of RNA levels in mutants were
represented relative to RNA levels in dslacZ-treated S2 cells. Primers used in these
experiments are described in Supplementary Table 1.
WB analyses. WB analyses were performed according to conventional methods.
Full scans of the WB presented in Figures and Supplementary Figures are shown in
Supplementary Fig. 12.
ChIP experiments. For preparing chromatin for ChIP, S2 cells were crosslinked
for 10min by adding 1.8% formaldehyde directly to the media and incubating on
the shaker at room temperature. Glycin (125mM) was added to stop the reaction.
Cells were washed once each with PBS, Wash Buffer A (10mM HEPES pH 7.9,
10mM EDTA, 0.5mM EGTA and 0.25% Triton X-100) and Wash Buffer B
(10mM HEPES pH 7.9, 100mM NaCl, 1mM EDTA, 0.5mM EGTA and 0.01%
Triton X-100). The pellet was then resuspended in TE and 1% SDS was added,
followed by centrifugation at 1,500g. The supernatant was carefully removed and
two washes with TE were performed. Then TE buffer, 0.1% SDS and 1mM PMSF
were added. Sonication was performed using the 15-ml tube holder of a Bioruptor
sonicator. A total of 25 sonication cycles of 30 s ON/30 s OFF were performed at
high intensity. After sonication, 1% Triton X-100, 0.1% deoxycholate and 140mM
NaCl were added. Samples were cleared using centrifugation and aliquots were
stored at  80 C. Before performing the ChIP, chromatin samples were precleared
for 1 h with Protein A sepharose. Antibody was added to the precleared chromatin
and rotated overnight at 4 C. Protein A sepharose was added and incubation was
continued for 3 h. Five washes with RIPA buffer (140mM NaCl, 10mM Tris-HCl
pH 8, 1mM EDTA, 1% Triton X-100, 0.1% SDS and 0.1% Deoxycholate), one wash
with LiCl ChIP buffer (250mM LiCl, 10mM Tris-HCl pH 8, 1mM EDTA, 0.5%
NP-40 and 0.5% Deoxycholate) and two washes with TE buffer were performed.
After RNAse treatment, elution was performed in 0.1M NaHCO3, 1% SDS and by
extensive vortexing. Eluates were de-crosslinked overnight at 65 C. Then, samples
were treated with Proteinase K and a Phenol–Chloroform DNA extraction followed
by EtOH precipitation was performed.
For ChIP–qPCR, triplicated samples were analysed using the standard curve
method. Normalization was performed with respect to the corresponding control
sample. Primers used in these experiments are described in Supplementary Table 1.
Relative abundance at TSS was determined by calculating the proportion of Rpb3
(or Pol IIoser5) detected at the peak position, as compared with the total amount of
Rpb3 (or Pol IIoser5) detected at all the analized positions along the gene. For ChIP-
seq, 10 ng of DNA, quantiﬁed with the Qubit dsDNA HS Assay Kit (Invitrogen)
was used for library preparation. End-repair, adenylation, ligation of adapters and
PCR enrichment for 18 cycles were performed using TruSeqRNA Sample Prep Kit
(Illumina) according to the manufacturer’s recommendations. Puriﬁed libraries
were quantiﬁed with the Qubit dsDNA HS Assay Kit (Invitrogen) and size
distribution was evaluated using the Bioanalyzer DNA 1000 assay (Agilent). Single-
end sequencing of 50 nucleotides was performed on the Genome Analyzer IIx.
For treatment with Actinomycin D, 15 106 cells were seeded in 15ml of
medium, grown for 48 h and then treated for 30min with 1 mgml 1 Actinomycin
D (Sigma A1410) or dimethylsulphoxide, as control, and then processed for ChIP-
qPCR as described above.
Bioinformatics and biostatistics analyses. Except where otherwise indicated, all
analyses were performed with the Bioconductor software. For analysis of ChIP-seq
data, Solexa/Illumina sequencing data for WOC, ROW, dHP1c and dDsk2 were
pre-processed with the standard Illumina pipeline version 1.5.1. Sequence align-
ment to the Drosophila melanogaster genome (UCSC dm3 version) and binding
site determination were performed essentially as described in ref. 66 setting the
coverage difference between IP and the corresponding input sample to 30 reads for
WOC and ROW, and 20 reads for dHP1c and dDsk2. ChIP-Seq proﬁles and
binding sites were deposited in the NCBI Gene Expression Omnibus repository
(GSE49102). Binding sites were assigned to overlapping and closest genes using the
UCSC refﬂat gene annotations (http://hgdownload.cse.ucsc.edu/goldenPath/dm3/
database/refFlat.txt.gz; April 2013) considering the longest possible transcript for
each gene and using the annotatePeakInBatch from the ChIPpeakAnno
Bioconductor package for annotation. Distance to overlapping and closest genes
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was measured from the midpoint of the peak to the gene TSS. To determine the
distribution of ChIP-seq reads around the TSS, we plotted the average read
coverage using the function plotMeanCoverage in the Bioconductor package
htSeqTools. Peak density around loci of interest was plotted using the
PeakLocation function from the htSeqTools package.
Gene ontology (GO) and KEGG enrichment pathway analyses were performed
as described in ref. 66 and statistical signiﬁcance assessed with Fisher’s exact test,
with Benjamini–Yekutieli multiple testing adjustment.
When dHP1c abundance at WOC/ROW/dHP1c target genes was compared
with abundance at WOC/ROW target and non-target genes, we computed the
reads per kilobase per million (RPKM) as 106 R/(ML), where R is the number of
reads mapped to a given gene, M is the total number of reads and L is the distance
between TSS and TES in kb.
ChIP-on-chip-binding site data for dHP1b, dHP1c and H2Bub1 were obtained
from modENCODE (IDs 941, 3291 and 290) and ChIP-seq-binding site data for
Pol IIoSer5 from NCBI GEO (GSE19325)68. ChIP-on-chip data for NELF-E were
downloaded from ArrayExpress (E-MEXP-1547)69 and binding sites were
determined with the rMAT package. First, arrays were normalized using the
NormalizeProbes function with the PairBinned method. Then, probe intensity
scores were computed with the computeMATScore function, setting the dMax
option to 150. Finally, binding sites were detected as enriched regions with the
callEnrichedRegions function, using the following options: dMax¼ 150,
dMerge¼ 150, nProbesMin¼ 8, and setting the false discovery rate threshold at
0.01. Binding sites were annotated to the D. melanogaster reference genome as
described above for ChIP-seq peaks. Peak density plots were produced using the
PeakLocation function from the htSeqTools package.
Total RNA pol II (RPB1) ChIP-Seq data (reads and binding sites) were
downloaded from NCBI GEO (GSE32120)70. Binding sites were annotated as
described above. Standardized peak density plots were determined using the
StdPeakLocation function in the htSeqTools package. The PI was computed for all
genes longer than 500 bp as the ratio between RPKM detected within ±250 bp
around the TSS and in the last 500 bp of the gene24. Statistical signiﬁcance for PI
difference was assessed using the Kruskal–Wallis test.
Genome-wide data for KMnO4 reactivity were downloaded from NCBI GEO
(GSE46620)27. First, reactive sites were deﬁned as those with a Thymine-reactivity
score (T-score) above the third quartile and annotated for overlapping genes as
described before. Per-gene T-score was computed as the sum of T-score values
across the whole gene and normalized by gene length. Genes were then classiﬁed
according to the resulting score as low (min to ﬁrst quartile), medium (ﬁrst to third
quartile) or high (third quartile to max), to assess the proportion of identiﬁed
targets within each KMnO4 reactivity score gene set. Benjamini–Yekutieli adjusted
P values for the observed proportion differences were computed with the Fisher’s
exact test.
shortRNA-Seq data were downloaded from NCBI GEO (GSE18643)26.
shortRNA sites were deﬁned as those with a score above the third quartile and
annotated for overlapping genes as described above.
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